CNBC's "Fast Money"

• Big Tech Earnings On Deck… And Charter’s Post-Results Slide 7/25/25

  Looking forward to a packed slate next week, with Apple, Meta, Amazon and Microsoft earnings on deck and a looming Fed decision. Plus, details on the Synovus-Pinnacle merger and a top analyst’s take on Charter’s post-earnings plunge. Fast Money Disclaimer

  --------  

  43:13

  --------

  43:13
• Showdown At The Fed… And Another Hit For UnitedHealth As The DoJ Investigates 7/24/25

  All eyes on the Fed as President Trump embarks on a rare presidential visit to the central bank amid its contested renovations. And, UnitedHealth drops after it confirms it’s responding to government probes into its Medicare operations. Plus, Chipotle sinks on its earnings miss, while airlines lose altitude. Fast Money Disclaimer

  --------  

  43:37

  --------

  43:37
• Alphabet And Tesla Report… And Tariff News Causing Global Market Moves 7/23/25

  Alphabet and Tesla kick off earnings season for the Mag-7, and Deepwater’s Gene Munster is weighing in on the tech results. Plus, Stocks jumping on the latest tariff news, including Trump’s trade deal with Japan. And even more earnings action with Chipotle, IBM and Las Vegas Sands all reporting.  Fast Money Disclaimer 

  --------  

  43:38

  --------

  43:38
• Changes In The Housing Market… And Fears After Netflix Earnings 7/22/25

  President Trump weighing a plan to remove cap gains tax on housing sales. Why one chief economist thinks the move could send home prices spiking. Plus, a Netflix bull worries about the streaming giant after last week’s quarterly results. And earnings season continues, with Texas Instruments, General Motors and Lockheed Martin making moves.   Fast Money Disclaimer

  --------  

  43:41

  --------

  43:41
• Google’s Pre-Earnings Win Streak… And Sarepta’s Dismal Outlook 7/21/25

  Google riding high ahead of earnings, with potential for its longest win streak in years. Japan’s election results have the Yen strengthening against the dollar. And Sarepta’s slide continues as the drug developer rebukes the FDA’s request to halt shipments of its gene therapy drug. Why one Wall Street analyst says the stock could head to zero. Fast Money Disclaimer  

  --------  

  43:43

  --------

  43:43

More Business podcasts

Trending Business podcasts

About CNBC's "Fast Money"

CNBC's "Fast Money": Podcasts in Family